门冬胰岛素30治疗初发2型糖尿病150例临床观察

Clinical Observation of Insulin Aspart 30 Treatment on Incipient Type 2 Diabetes Mellitus Which Includes 150 Cases

目的:探讨门冬胰岛素30(诺和锐30)对初发2型糖尿病患者治疗的疗效和安全性。方法:采用自身对照的方法,使用诺和锐30对150例初发2型糖鼠病患者进行6周的治疗,观察治疗前后患者FP G、2hPG、HbA1C、FC、2hC、HOMA-β、HOMA-IR等指标的水平。结果:诺和锐30治疗后,FPG、2hPG、HbA1C、HOMA-IR均显著下降(P<0.05),FC、2hC、HOMA-β显著上升(P<0.05)。结论:诺和锐30可以显著改善初发2型糖尿病患者的血糖和胰岛功能,且安全性良好。

Objective：To discuss the curative effect and safety of insulin aspart 30 treatment on incipient type 2 diabetes mcllitus.Methods：Using self control.Methods：Carried a 6 weeks long treat which using insulin as part 30 in 150 cases,observe the FPG,2hPG,HbA1C,FC,2hC,HOMA-β,HOMA-IR between before and after treatment.Results：After insulin as part 30 treatment, FPG,2hPG,HbA1C,HOMA-IR got a notable decrease（P0.05）,and FC,2hC.HOMA- P got a notable rising.Conclusions：Insulin aspart 30 can notable improve blood sugar and pancreas islet function of patients who got incipient type 2 diabetes mellitus,while has a good safety.